View Presentation - Society of Thoracic Radiology

David M. Hansell, MD, FRCR, FRCP, FRSM ESTI SPEAKER
SUNDAY
Pitfalls in the HRCT Diagnosis of Fibrosing Lung
Disease
• Why segregate fibrosing lung disease from other
DLDs?
Pitfalls in the HRCT diagnosis
of fibrosing lung disease
• What are the HRCT signs of fibrosing DLD?
–
reliability of signs
• Diagnostic HRCT algorithm for fibrosing DLD
• Problems in fibrosing DLD
David M Hansell
Royal Brompton Hospital
London UK
– HRCT off non-classical
l
l UIP
– HRCT pitfalls in acute exacerbation of IPF
Why consider fibrotic ILD and
non-fibrotic ILD separately?
• Expectation of certain disease behavior
– Idiopathic pulmonary fibrosis in particular
• Prospect of enrolment into drug trial
• Differential diagnosis
g
much shorter
(bonus!)
BASICS
HRCT signs of a predominantly fibrotic
lung disease:
• Honeycombing
• Traction bronchiectasis
• Volume loss
Reliability of HRCT signs of fibrotic
lung disease
(++++ = complete certainty)
Honeycombing
• Honeycomb pattern
+++(+)
• Traction bronchiectasis
++(+)
• Volume loss
+
Traction bronchiectasis
Volume loss
85
SUNDAY
Honeycomb pattern
Traction bronchiectasis
Volume loss
Honeycombing
Identification of honeycombing on
HRCT - cardinal sign of UIP
• False positive identification
– Centrilobular/paraseptal emphysema
e.g. superimposed on NSIP
– Severe traction bronchiolectasis
– Other cystic conditions e.g. Langerhans CH
• (False negative)
– Microcystic
y
or microscopic
p honeycombing
y
g (path)
(p )
86
SUNDAY
Lung biopsy: Fibrotic NSIP and centrilobular emphysema
Interobserver variability in the CT
assessment of honeycombing in the lungs
Historically poor: Lynch et al (2005) =0.31
• 43 observers
b
(!)
• Honeycombing present definitely yes (5) thro’
d fi it l nott (1)
definitely
• Agreement with reference standard moderate
0 43 0 58
=0.43-0.58
• In 29% disagreement on presence/absence
• Sources
S
off di
disagreement:
t ttraction
ti bx,
b cysts
t and
d
superimposed emphysema
Watadani et al Radiology 2013;266:207
Identification of traction
bronchiectasis on HRCT
• False positive identification
Traction bronchiectasis
– Within honeycombing
– Dilated bronchi within OP
– Airwayy dilatation in acute lungg injury
j y
– Conspicuous, but not dilated, bronchi within GGO
• False negative
– Within honeycombing (usually advanced)
87
SUNDAY
After withdrawal
of nitrofurantoin
Sheehan et al J Thorac Imag 2000;24:259
Observer agreement for traction
bronchiectasis in various FLD
• Fibrotic IIPs (UIP and NSIP)
– Edey 2011 Eur Radiol
• Rheumatoid Arthritis-related FLD
– Kim
Ki 2010 Eur
E Respir
R i J
• Chronic hypersensitivity pneumonitis
– Walsh SL 2012 Eur Radiol
• All comers connective tissue disease FLD
– Walsh SL unpublished
p
data
Kappas for traction bronchiectasis = 0.58 - 0.69
Study by Sakai et al - in progress
88
Interlobular septal
p thickeningg in
fibrosing lung disease
• A common feature in UIP – not really!
• Rarely
R l conspicuous
i
iin NSIP
• If prominent, nodular and lower zone
consider sarcoidosis as the cause of the FLD
• May be an early sign of supervening fibrosis
in subacute hypersensitivity pneumonitis
SUNDAY
Two examples of NSIP
Two examples of sarcoidosis
Coche et al.
al Br J Radiol 2001;74:189
Two examples of chronic
hypersensitivity
h
iti it pneumonitis
iti
HRCT pointers to chronic hypersensitivity
pneumonitis
• Lobules of decreased attenuation in spared (nonfibrotic) lung
• Septal thickening tends to be more prominent than
in fibrotic IIPs
• Unusual distribution of fibrosis, particularly vague
bronchocentricity in upper lobes
• Coexistent subacute changes - indistinct relatively
low attenuation centrilobular nodules (rare)
89
SUNDAY
Lobules of decreased attenuation in spared
p
lungg
Chronic hypersensitivity with UIP features
Unusual distribution of fibrosis,, particularly
p
y
vague bronchocentricity in upper lobes
Scheme for HRCT of fibrosing
lung disease:
• Is it a fibrosingg lungg disease (3
( signs)?
g )
• If yes, is it classical UIP?
• If no, what are the choices?
Characteristic/Classical HRCT pattern of UIP
• Subpleural
• Basal
• Honeycombing
ALSO…
• “Propeller
Propeller blade”
blade cranio-caudal
cranio caudal distribution
• Absence of atypical features,
features in particular:
Subpleural basal honeycombing UIP
90
– Lobules of decreased attenuation in spared lung
– Consolidation
SUNDAY
If not typical UIP:
• Non-classical
N
l i l UIP
– Older increasing likelihood of UIP
Fell CD et al. AJRCCM 2010;181:832
• Non-specific
p
interstitial p
pneumonia ((NSIP))
• Chronic hypersensitivity pneumonitis
• Fibrotic sarcoidosis
• ((Fibrosingg variant of organizing
g
g pneumonia)
p
)
OP
OP
UIP
UIP
NSIP
HP
NSIP
LIP
HP
DIP/
RB-ILD
“Other HRCT diagnoses” in
patients with biopsy proven UIP
• 3 observers assigned diagnoses to HRCTs of 123
cases (core of 55 patients with biopsy proven UIP)
• 34/55 (62%) considered not to be typical of UIP:
– NSIP 18/34 (53%); HP (12%); sarcoidosis (9%)
A diagnosis of IPF is not excluded by HRCT
appearances more suggestive
tiv off NSIP
Sverzellati et al Radiology 2010;254:957
LIP
DIP/
RB-ILD
UIP pattern
(all four features)
Possible UIP pattern
(all three features)
• Subpleural basal
predominance
• Subpleural basal
predominance
• Reticular abnormality
• Reticular abnormality
Inconsistent with UIP pattern
(any one of seven features)
• Upper or mid lung
predominance
• Peribronchovascular
predominance
• Extensive ground glass
abnormality (extent > reticular
abnormality)
• Profuse micronodules
(bilateral predominantly upper
(bilateral,
lobes)
• Honeycombing with or without
traction bronchiectasis
• Discrete cysts (multiple
bilateral, away from areas of
honeycombing)
• Diffuse mosaic attenuation/air
trapping (bilateral in three or
more lobes)
• Absence of features listed as
inconsistent with UIP pattern
• Absence of features
listed as inconsistent
with UIP pattern
• Consolidation in bronchopulmonary segment(s)/lobe(s)
“Possible”
Possible no HC, no inconsistent features
ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;183:788
91
SUNDAY
Range of HRCT appearances of
non classical UIP
non-classical
Does a definite diagnosis of
IPF/UIP matter?
• YES!
– For the patient/doctor: prognosis
– For exclusion of cryptic
yp driver of the
disease
– For possible entry into drug trial
…not fully explored
Acute exacerbation (accelerated phase) of IPF
“Iff it behaves like UIP it is UIP…”
ATS/ERS statement - IIP update 2013:
C
Consensus
on di
diagnosis
i and
d managementt
HR Collard et al. AJRCCM 2007;176: 636
Acute Exacerbation
5 weeks
eek later
lat
92
Differential diagnosis for recent onset of
widespread ground glass opacification in
IPF/UIP:
•
•
•
•
•
•
Accelerated phase of the disease
S
Supervening
i h
heartt ffailure
il
((oedema)
d
)
Opportunistic infection (PCP/CMV)
Drug reaction – esp. novel drugs
((Spurious
p
– expiratory
p
y CT))
(Spurious – contrast in CTPA)
SUNDAY
Pulmonary oedema
P
Pneumocystis
ti pneumonia
i
Expiratory CT
Points
• Three
Th
basic
b i signs
i
off fib
fibrosing
i llung di
disease
• Issues with certain identification of
honeycombing and traction bronchiectasis
• Main HRCT differential of fibrosing lung
disease is UIP -v- chronic HP/NSIP
CTPA (contrast)
• C
Considerations
id ti
when
h HRCT appearances are
suggestive of acute exacerbation
93